Author

Séverine Loisel

Université de Bretagne OccidentaleORCID 0000-0002-4388-9933Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Angelita RebolloiD· 1 shared Asma Touffeil Mohamed· 1 shared Fanny PetitiD· 1 shared Gwenaëlle Aurégan· 1 shared Kristina Põšnograjeva· 1 shared Marjorie Benfissa· 1 shared Martine Guillermier· 1 shared Pauline Gipchtein· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Angelita RebolloORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Brain-specific PP1/LRRK2 interaction-targeting peptides as a novel strategy for Parkinson's disease treatment

Séverine Loisel, Fanny Petit, Gwenaëlle Aurégan, Martine Guillermier, Marjorie Benfissa, Pauline Gipchtein, Asma Touffeil Mohamed, Kristina Põšnograjeva, Tambet Teesalu, Romina Aron Badin, Angelita Rebollo

The paper develops a peptide, PEP 3, that disrupts the LRRK2/PP1 interaction and shows promise as a therapeutic for Parkinson's disease by reducing dopaminergic cell death and alpha-synuclein phosphorylation.

bioRxiv · Jul 29, 2026 · PreprintNeuroscience